BOSTON and CAMBRIDGE, Mass., Oct. 18, 2017 /PRNewswire/ -- The Massachusetts Biotechnology Council (MassBio) is teaming up with Powering Precision Health Summit to improve patient lives by advancing cutting-edge research that will transform today's reactive sick care into a proactive and preventative healthcare model. The summit will take place on October 24th and 25th at the Charles Hotel in Cambridge.
"We have an enormous opportunity to usher in personalized precision health by measuring molecular disease triggers with digital detection biomarker technology, and then pairing these capabilities with environmental factors in ways that enable us to see disease earlier and less invasively," said Kevin Hrusovsky, Founder & Chairman, Powering Precision Health Summit. "We are advancing scientific breakthroughs on a path to prevent and cure some of life's most lethal diseases, including cancer, heart disease and neurodegenerative disease."
"Massachusetts is a global leader in the life sciences and our administration fully supports efforts to advance research and collaboration like the upcoming Powering Precision Health Summit," said Governor Charlie Baker. "We look forward to the ideas and projects the summit's medical experts will develop to continue groundbreaking scientific research partnerships, spur new precision technologies and support Massachusetts' nation-leading innovation economy."
Earlier this year, the Baker-Polito Administration announced a legislative proposal to bolster Massachusetts' leadership in the life sciences sector, providing up to $500 million over five years for strategic investments in public infrastructure, research and development, workforce training and education, including up to $295 million in capital authorization and up to $150 million job-creating tax incentives. Additionally, Governor Charlie Baker and the Massachusetts Life Science Center announced $39 million in capital funding for research centers and life sciences training facilities at colleges, universities, middle schools and high schools across the Commonwealth.
"MassBio is committed to precision health and this summit is pivotal in moving research and development toward finding a cure," said Bob Coughlin, President and CEO of MassBio. "Partnering with an event that supports patient-driven, personalized solutions to today's most difficult to diagnose and treat diseases only reinforces our commitment to the cause."
The second annual Powering Precision Health Summit will feature over 50 medical experts hailing from the nation's top medical institutions, including Harvard, Tufts, Yale, MIT, Massachusetts General Hospital, Boston University, MD Anderson Cancer Center, Dana Farber, Cedars-Sinai and Penn State. These speakers represent the leading biomarker researchers and clinicians in the U.S. who are working to collaborate on a cure for cancers, such as breast cancer and pancreatic cancer, for neurodegenerative diseases including Alzheimer's Disease, ALS, CTE, and for metabolic and cardiovascular diseases.
For info on the summit and to register for free online go to: https://goo.gl/fNkU3o.
About Powering Precision Health
Powering Precision Health is the nation's first summit dedicated to bringing the world's top physicians, scientists, innovators and patient advocates together to collaborate on the latest research on new biomarkers that are revolutionizing medicine. Founded by Kevin Hrusovsky, the acclaimed thought leader and visionary in life sciences and personalized medicine, PPHS is an executive think tank of researchers and clinicians working together to transform healthcare. Addressing key therapeutic areas including neurology, cardiology, oncology and infectious disease, PPHS unveils groundbreaking approaches for the prevention, early detection and diagnosis, and personalized treatment of disease. Join the movement on social media using #PPHSUMMIT on Twitter @KevinHrusovsky and @PPHSUMMIT, Facebook @PPHSUMMIT, and LinkedIn.
MassBio is a not-for-profit organization founded in 1985 that represents and provides services and support for the Massachusetts life sciences industry. MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000+ biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs, events, industry information, and services.
Media Contact: Heidi Creighton, 978-302-1198, email@example.com
SOURCE Powering Precision Health Summit